Sonic Healthcare Limited (OTCMKTS:SKHHY - Get Free Report) announced a dividend on Thursday, February 20th, NASDAQ Dividends reports. Shareholders of record on Thursday, March 6th will be paid a dividend of 0.2816 per share on Monday, March 31st. The ex-dividend date is Thursday, March 6th.
Shares of Sonic Healthcare stock traded down $0.79 on Friday, reaching $17.29. 18,815 shares of the company were exchanged, compared to its average volume of 33,586. The company's 50-day moving average is $17.53 and its two-hundred day moving average is $17.94. Sonic Healthcare has a 1-year low of $15.24 and a 1-year high of $20.59.
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Sonic Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonic Healthcare wasn't on the list.
While Sonic Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.